These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
345 related articles for article (PubMed ID: 30115920)
1. Discovery of cationic nonribosomal peptides as Gram-negative antibiotics through global genome mining. Li YX; Zhong Z; Zhang WP; Qian PY Nat Commun; 2018 Aug; 9(1):3273. PubMed ID: 30115920 [TBL] [Abstract][Full Text] [Related]
2. The Total Chemical Synthesis and Biological Evaluation of the Cationic Antimicrobial Peptides, Laterocidine and Brevicidine. Hermant Y; Palpal-Latoc D; Kovalenko N; Cameron AJ; Brimble MA; Harris PWR J Nat Prod; 2021 Aug; 84(8):2165-2174. PubMed ID: 34338512 [TBL] [Abstract][Full Text] [Related]
3. Potentiation of Antibiotic Activity by a Novel Cationic Peptide: Potency and Spectrum of Activity of SPR741. Corbett D; Wise A; Langley T; Skinner K; Trimby E; Birchall S; Dorali A; Sandiford S; Williams J; Warn P; Vaara M; Lister T Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28533232 [TBL] [Abstract][Full Text] [Related]
4. In vitro activity of novel in silico-developed antimicrobial peptides against a panel of bacterial pathogens. Romani AA; Baroni MC; Taddei S; Ghidini F; Sansoni P; Cavirani S; Cabassi CS J Pept Sci; 2013 Sep; 19(9):554-65. PubMed ID: 23893489 [TBL] [Abstract][Full Text] [Related]
5. A novel polycationic analogue of gratisin with antibiotic activity against both Gram-positive and Gram-negative bacteria. Tamaki M; Kokuno M; Suzuki Y; Iwama M; Shindo M; Uchida Y J Antibiot (Tokyo); 2008 Jan; 61(1):33-5. PubMed ID: 18305357 [TBL] [Abstract][Full Text] [Related]
6. Synergistic activity profile of an antimicrobial peptide against multidrug-resistant and extensively drug-resistant strains of Gram-negative bacterial pathogens. Pollini S; Brunetti J; Sennati S; Rossolini GM; Bracci L; Pini A; Falciani C J Pept Sci; 2017 Apr; 23(4):329-333. PubMed ID: 28176481 [TBL] [Abstract][Full Text] [Related]
7. Azithromycin Synergizes with Cationic Antimicrobial Peptides to Exert Bactericidal and Therapeutic Activity Against Highly Multidrug-Resistant Gram-Negative Bacterial Pathogens. Lin L; Nonejuie P; Munguia J; Hollands A; Olson J; Dam Q; Kumaraswamy M; Rivera H; Corriden R; Rohde M; Hensler ME; Burkart MD; Pogliano J; Sakoulas G; Nizet V EBioMedicine; 2015 Jul; 2(7):690-8. PubMed ID: 26288841 [TBL] [Abstract][Full Text] [Related]
9. Selective antibacterial activity of the cationic peptide PaDBS1R6 against Gram-negative bacteria. Fensterseifer ICM; Felício MR; Alves ESF; Cardoso MH; Torres MDT; Matos CO; Silva ON; Lu TK; Freire MV; Neves NC; Gonçalves S; Lião LM; Santos NC; Porto WF; de la Fuente-Nunez C; Franco OL Biochim Biophys Acta Biomembr; 2019 Jul; 1861(7):1375-1387. PubMed ID: 30926365 [TBL] [Abstract][Full Text] [Related]
10. Dilipid ultrashort cationic lipopeptides as adjuvants for chloramphenicol and other conventional antibiotics against Gram-negative bacteria. Domalaon R; Brizuela M; Eisner B; Findlay B; Zhanel GG; Schweizer F Amino Acids; 2019 Mar; 51(3):383-393. PubMed ID: 30392097 [TBL] [Abstract][Full Text] [Related]
11. Antimicrobial activity of bovine bactericidal permeability-increasing protein-derived peptides against gram-negative bacteria isolated from the milk of cows with clinical mastitis. Chockalingam A; Zarlenga DS; Bannerman DD Am J Vet Res; 2007 Nov; 68(11):1151-9. PubMed ID: 17975968 [TBL] [Abstract][Full Text] [Related]
12. Battacin (Octapeptin B5), a new cyclic lipopeptide antibiotic from Paenibacillus tianmuensis active against multidrug-resistant Gram-negative bacteria. Qian CD; Wu XC; Teng Y; Zhao WP; Li O; Fang SG; Huang ZH; Gao HC Antimicrob Agents Chemother; 2012 Mar; 56(3):1458-65. PubMed ID: 22183171 [TBL] [Abstract][Full Text] [Related]
13. A peptide derived from human bactericidal/permeability-increasing protein (BPI) exerts bactericidal activity against Gram-negative bacterial isolates obtained from clinical cases of bovine mastitis. Chockalingam A; McKinney CE; Rinaldi M; Zarlenga DS; Bannerman DD Vet Microbiol; 2007 Nov; 125(1-2):80-90. PubMed ID: 17560054 [TBL] [Abstract][Full Text] [Related]
14. Treatment of Gram-negative bacterial infections by potentiation of antibiotics. Zabawa TP; Pucci MJ; Parr TR; Lister T Curr Opin Microbiol; 2016 Oct; 33():7-12. PubMed ID: 27232956 [TBL] [Abstract][Full Text] [Related]
15. Antimicrobial AApeptides. Sang P; Shi Y; Teng P; Cao A; Xu H; Li Q; Cai J Curr Top Med Chem; 2017; 17(11):1266-1279. PubMed ID: 27758686 [TBL] [Abstract][Full Text] [Related]
16. A bioinspired peptide scaffold with high antibiotic activity and low in vivo toxicity. Rabanal F; Grau-Campistany A; Vila-Farrés X; Gonzalez-Linares J; Borràs M; Vila J; Manresa A; Cajal Y Sci Rep; 2015 May; 5():10558. PubMed ID: 26024044 [TBL] [Abstract][Full Text] [Related]
17. Antimicrobial Peptides with High Proteolytic Resistance for Combating Gram-Negative Bacteria. Wang J; Song J; Yang Z; He S; Yang Y; Feng X; Dou X; Shan A J Med Chem; 2019 Mar; 62(5):2286-2304. PubMed ID: 30742437 [TBL] [Abstract][Full Text] [Related]
18. Lipidated α/α-AA heterogeneous peptides as antimicrobial agents. Singh S; Nimmagadda A; Su M; Wang M; Teng P; Cai J Eur J Med Chem; 2018 Jul; 155():398-405. PubMed ID: 29906686 [TBL] [Abstract][Full Text] [Related]
19. Functional synergy of α-helical antimicrobial peptides and traditional antibiotics against Gram-negative and Gram-positive bacteria in vitro and in vivo. Feng Q; Huang Y; Chen M; Li G; Chen Y Eur J Clin Microbiol Infect Dis; 2015 Jan; 34(1):197-204. PubMed ID: 25169965 [TBL] [Abstract][Full Text] [Related]
20. Cathelicidin Antimicrobial Peptides with Reduced Activation of Toll-Like Receptor Signaling Have Potent Bactericidal Activity against Colistin-Resistant Bacteria. Kao C; Lin X; Yi G; Zhang Y; Rowe-Magnus DA; Bush K mBio; 2016 Sep; 7(5):. PubMed ID: 27651360 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]